The Oncology Institute, Inc. TOI Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $147.44M+3.9% | $141.96M+3.9% | $136.56M+14.0% | $119.8M+14.7% | $104.41M+4.1% | ||
| $28.21M+0.6% | $28.04M+11.0% | $25.25M-6.2% | $26.91M+6.0% | $25.38M+2.1% | ||
| $1.62M-1.0% | $1.63M-5.3% | $1.72M-4.5% | $1.81M+1.2% | $1.78M+4.5% | ||
| $153.95M+3.4% | $148.86M+2.9% | $144.62M+10.4% | $131.01M+14.6% | $114.32M+1.9% | ||
| -$6.51M+5.7% | -$6.91M+14.2% | -$8.05M+28.2% | -$11.21M-13.1% | -$9.91M+16.9% | ||
| -4.4%+0.4pp | -4.9%+1.0pp | -5.9%+3.5pp | -9.4%+0.1pp | -9.5%+2.4pp | ||
| $1.93M+0.9% | $1.92M-0.2% | $1.92M+2.7% | $1.87M-66.4% | $5.57M+377% | ||
| $4.02M+769% | -$601K+92.9% | -$8.45M-42.5% | -$5.93M+38.7% | -$9.67M-672% | ||
| -$2.49M+66.8% | -$7.51M+54.5% | -$16.5M+3.7% | -$17.14M+12.5% | -$19.59M-48.6% | ||
| $0— | $0— | $0+100% | -$131K— | $0— | ||
| -$2.49M+66.8% | -$7.51M+54.5% | -$16.5M+3.0% | -$17.01M+13.2% | -$19.59M-48.6% | ||
| -1.7%+3.6pp | -5.3%+6.8pp | -12.1%+2.1pp | -14.2%+4.6pp | -18.8%-5.6pp | ||
| -$0.02+60.0% | -$0.05+64.3% | -$0.14+6.7% | -$0.15+28.6% | -$0.21-40.0% | ||
| -$0.02+60.0% | -$0.05+64.3% | -$0.14+6.7% | -$0.15+28.6% | -$0.21-40.0% | ||
| 101.8M+10.2% | 92.4M-5.2% | 97.5M+4.6% | 93.2M+20.9% | 77.1M+2.7% | ||
| 101.8M+10.2% | 92.4M-5.2% | 97.5M+4.6% | 93.2M+20.9% | 77.1M+2.7% | ||
| $5M— | $0+100% | -$5.98M-49.9% | -$3.99M-20.5% | -$3.31M-2,665% | ||
| $791K— | —— | -$403K-2,021% | -$19K+97.5% | -$752K-188% | ||
| $147.44M+3.9% | $141.96M+3.9% | $136.56M+14.0% | $119.8M+14.7% | $104.41M+4.1% | ||
| -$6.51M+5.7% | -$6.91M+14.2% | -$8.05M+28.2% | -$11.21M-13.1% | -$9.91M+16.9% | ||
| -$4.9M+7.2% | -$5.28M+16.7% | -$6.33M+32.7% | -$9.41M-15.7% | -$8.13M+20.5% | ||
| -$4.9M+7.2% | -$5.28M+16.7% | -$6.33M+32.7% | -$9.41M-15.7% | -$8.13M+20.5% | ||
| -3.3%+0.4pp | -3.7%+0.9pp | -4.6%+3.2pp | -7.9%-0.1pp | -7.8%+2.4pp | ||
| -$6.51M+5.7% | -$6.91M+14.2% | -$8.05M+28.2% | -$11.21M-13.1% | -$9.91M+16.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is The Oncology Institute, Inc.'s revenue?
- The Oncology Institute, Inc. (TOI) generated $545.8M in revenue over the trailing twelve months, up 35.4% year over year.
- Is The Oncology Institute, Inc. profitable?
- The Oncology Institute, Inc. is not currently profitable: it reported a net loss of $43.5M over the trailing twelve months, a -8.0% net margin.
- What is The Oncology Institute, Inc.'s earnings per share?
- The Oncology Institute, Inc.'s diluted EPS over the trailing twelve months is $-0.36.
- Where does The Oncology Institute, Inc.'s income statement data come from?
- Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
